116 related articles for article (PubMed ID: 2107984)
1. Role of thromboxane A2 in the cardiovascular response to intracoronary C5a.
Stahl GL; Amsterdam EA; Symons JD; Longhurst JC
Circ Res; 1990 Apr; 66(4):1103-11. PubMed ID: 2107984
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane A2 and peptidoleukotrienes contribute to the myocardial ischemia and contractile dysfunction in response to intracoronary infusion of complement C5a in pigs.
Ito BR; Roth DM; Engler RL
Circ Res; 1990 Mar; 66(3):596-607. PubMed ID: 2137727
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane is produced in response to intracoronary infusions of complement C5a in pigs. Cyclooxygenase blockade does not reduce the myocardial ischemia and leukocyte accumulation.
Ito BR; Roth DM; Chenoweth DE; Lefer AM; Engler RL
Circ Res; 1989 Nov; 65(5):1220-32. PubMed ID: 2509096
[TBL] [Abstract][Full Text] [Related]
4. Intracoronary C5a induces myocardial ischemia by mechanisms independent of the neutrophil: leukocyte filters desensitize the myocardium to C5a.
Engler RL; Roth DM; del Balzo U; Ito BR
FASEB J; 1991 Nov; 5(14):2983-91. PubMed ID: 1661246
[TBL] [Abstract][Full Text] [Related]
5. C5a-induced myocardial ischemia: role for CD18-dependent PMN localization and PMN-platelet interactions.
Fletcher MP; Stahl GL; Longhurst JC
Am J Physiol; 1993 Nov; 265(5 Pt 2):H1750-61. PubMed ID: 7902015
[TBL] [Abstract][Full Text] [Related]
6. C5a decreases regional coronary blood flow and myocardial function in pigs: implications for a granulocyte mechanism.
Martin SE; Chenoweth DE; Engler RL; Roth DM; Longhurst JC
Circ Res; 1988 Aug; 63(2):483-91. PubMed ID: 3396162
[TBL] [Abstract][Full Text] [Related]
7. Role of cardiac mast cells in complement C5a-induced myocardial ischemia.
Ito BR; Engler RL; del Balzo U
Am J Physiol; 1993 May; 264(5 Pt 2):H1346-54. PubMed ID: 7684573
[TBL] [Abstract][Full Text] [Related]
8. Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.
Golino P; Ashton JH; Glas-Greenwalt P; McNatt J; Buja LM; Willerson JT
Circulation; 1988 Mar; 77(3):678-84. PubMed ID: 3124975
[TBL] [Abstract][Full Text] [Related]
9. Complement C5a-mediated myocardial ischemia and neutrophil sequestration: two independent phenomena.
Del Balzo U; Engler RL; Ito BR
Am J Physiol; 1993 Feb; 264(2 Pt 2):H336-44. PubMed ID: 8447449
[TBL] [Abstract][Full Text] [Related]
10. Contractile actions of C5a on isolated porcine myocardium.
Amsterdam EA; Rendig SV; Longhurst JC
Am J Physiol; 1992 Sep; 263(3 Pt 2):H740-5. PubMed ID: 1357981
[TBL] [Abstract][Full Text] [Related]
11. Effect of platelet depletion and inhibition of platelet cyclooxygenase on C5a-mediated myocardial ischemia.
Ito BR; Del Balzo U
Am J Physiol; 1994 Oct; 267(4 Pt 2):H1288-94. PubMed ID: 7943373
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.
Golino P; Ashton JH; McNatt J; Glas-Greenwalt P; Yao SK; O'Brien RA; Buja LM; Willerson JT
Circulation; 1989 Apr; 79(4):911-9. PubMed ID: 2494005
[TBL] [Abstract][Full Text] [Related]
13. Activation of leukocytes with complement C5a is associated with prostanoid-dependent constriction of large arteries in atherosclerotic monkeys in vivo.
Mügge A; Heistad DD; Densen P; Piegors DJ; Armstrong ML; Padgett RC; Lopez JA
Atherosclerosis; 1992 Aug; 95(2-3):211-22. PubMed ID: 1418094
[TBL] [Abstract][Full Text] [Related]
14. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
[TBL] [Abstract][Full Text] [Related]
15. Role of thromboxane A2 in the control of myocardial O2 supply/consumption balance and severity of ischemia during pacing-induced ischemia.
Grover GJ; Parham CS
Circ Res; 1989 Mar; 64(3):575-82. PubMed ID: 2917381
[TBL] [Abstract][Full Text] [Related]
16. In vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac function.
Dubé GP; Jakubowski JA; Brune KA; Bemis KG; Kurtz WL
J Pharmacol Exp Ther; 1995 Feb; 272(2):799-807. PubMed ID: 7853197
[TBL] [Abstract][Full Text] [Related]
17. Serotonin S2 and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries.
Ashton JH; Golino P; McNatt JM; Buja LM; Willerson JT
J Am Coll Cardiol; 1989 Mar; 13(3):755-63. PubMed ID: 2521875
[TBL] [Abstract][Full Text] [Related]
18. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia.
Schmitz JM; Apprill PG; Buja LM; Willerson JT; Campbell WB
Circ Res; 1985 Aug; 57(2):223-31. PubMed ID: 3926340
[TBL] [Abstract][Full Text] [Related]
19. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
Yao SK; Rosolowsky M; Anderson HV; Golino P; NcNatt JM; De Clerck F; Buja LM; Willerson JT
J Am Coll Cardiol; 1990 Sep; 16(3):705-13. PubMed ID: 2143767
[TBL] [Abstract][Full Text] [Related]
20. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs.
Sassen LM; Soei LK; Koning MM; Verdouw PD
Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
